PYODERMA GANGRENOSUM
Clinical trials for PYODERMA GANGRENOSUM explained in plain language.
Never miss a new study
Get alerted when new PYODERMA GANGRENOSUM trials appear
Sign up with your email to follow new studies for PYODERMA GANGRENOSUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising drug for rare skin ulcers shows early potential
Disease control TerminatedThis study tested a drug called spesolimab in 5 adults with moderate to severe pyoderma gangrenosum, a rare autoimmune disease that causes painful skin ulcers. The goal was to see if the drug could help ulcers heal and reduce their severity. The study was stopped early, so result…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated May 26, 2026 08:42 UTC
-
Experimental wound patch studied for rare skin ulcers
Disease control TerminatedThis study tested whether a special wound covering (EpiFix, made from donated amniotic membrane) could help heal painful skin ulcers caused by pyoderma gangrenosum. Five adults with the condition received the covering followed by a skin graft about a week later. The study was sto…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE4 • Sponsor: Louisiana State University Health Sciences Center in New Orleans • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Promising ulcer drug trial halted early – what it means for patients
Disease control TerminatedThis study tested a drug called vilobelimab for people with pyoderma gangrenosum, a rare condition that causes deep, painful skin ulcers. The trial aimed to see if the drug could completely close these ulcers better than a placebo. However, the study was stopped early, so the res…
Matched conditions: PYODERMA GANGRENOSUM
Phase: PHASE3 • Sponsor: InflaRx GmbH • Aim: Disease control
Last updated May 20, 2026 11:54 UTC